SEMA3D and hepatocellular carcinoma: We detected mRNA of Sema3d in the 3 clinical subtypes of HCC (Figure 1D), and the SLHCC and SHCC possessed low metastatic potentials and expressed relatively higher Sema3d than the NHCC with high metastatic potentials.